Less Than 50% of Accelerated Approvals Show Clinical Benefit Less Than 50% of Accelerated Approvals Show Clinical Benefit

A new study looks at 5-year outcomes of cancer drugs that were given accelerated approvals.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology Source Type: news